The Company offers a compelling combination of technology, services and clinical expertise, helping their customers to deliver successful clinical trial outcomes by ensuring high quality data-capture, reduced costs, and shortened study timelines. The ERT product suite encompasses six different product lines: eCOA, Cardiac Safety, Respiratory Safety & Efficacy, Imaging, Digital Patient and Trial Oversight.
ERT has established relationships with most blue-chip global pharma companies and Clinical Research Organizations (CROs). The Company is currently supporting more than 3,000 studies, and has been involved in more than 60% of all FDA drug approvals in the U.S. over the last 5 years.
Headquartered in Philadelphia (US), the company employs ca. 2,500 people globally.